Screening Tools for Colorectal Cancer

Recruiting in Palo Alto (17 mi)

Overseen byCelette Skinner, PhD

Age: 18 - 65

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Texas Southwestern Medical Center

No Placebo Group

Trial Summary

What is the purpose of this trial?

The overall goal of the Parkland-UT Southwestern Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) Center is to optimize colon cancer screening through personalized regimens in the integrated safety-net clinical provider network, which serves a large and diverse population of under- and un-insured patients in Dallas. Together, three research projects will assess clinic, system, and organizational factors associated with over-, under- and guideline-based screening among this important population and will compare benefits, harms, and costs of strategies for facilitating optimized screening regimens. The theme of optimizing colorectal cancer screening in a safety-net clinical provider network brings together several components. Its focus on colorectal cancer (CRC) screening which is important, because CRC is the second cancer killer in the US while being the only major cancer for which optimized screening results in primary prevention. Despite this strong potential benefit, CRC screening remains suboptimal overall, and especially among low-income and minority individuals served by safety-nets. Safety-net networks therefore offer tremendous potential for CRC prevention and control, but numerous factors at the clinics-, system-, and organization-level influence their ability to provide optimized care.

Research Team

Celette Skinner, PhD

Principal Investigator

UT Southwestern Medical Center

Eligibility Criteria

This trial is for men and women aged 25-64 who are visiting the clinic. Those aged 25-49 must have a family history of colorectal cancer or their own history of bowel disease or polyps. All racial and ethnic groups, as well as English and Spanish speakers, can join. People with personal colorectal cancer history, severe hearing/speech impairments, or without informed consent cannot participate.

Inclusion Criteria

I am between 25 and 64 years old.

No racial or ethnic group will be excluded from participation

I am aged 25-49 and have a family history of colon cancer or a personal history of bowel inflammation or polyps.

See 1 more

Exclusion Criteria

I have never had colorectal cancer.

I speak English or Spanish and can hear, speak, and have given my consent.

Treatment Details

Interventions

Algorithmic Risk Stratification Tool (Behavioural Intervention)
Computerized Risk Stratification Tool (Behavioural Intervention)
Step completion assessment (Behavioural Intervention)

Trial OverviewThe PROSPR project aims to find the best ways to screen for colon cancer in a diverse group using safety-net clinics. It will test tools like step completion assessments and computerized risk stratification algorithms to personalize screening methods based on individual risks.

Participant Groups

1Treatment groups

Experimental Treatment

Group I: ScreeningExperimental Treatment3 Interventions

Employ innovative methods for assessing personalized guideline-based screening in the clinic setting to evaluate guideline-based, over- and under-screening. Interventions include Computerized Risk Stratification Tool, Algorithmic Risk Stratification Tool, and Step completion assessment.